| European Case Law Identifier: | ECLI:EP:BA:2015:T102111.20150602 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 02 June 2015 | ||||||||
| Case number: | T 1021/11 | ||||||||
| Application number: | 06850366.3 | ||||||||
| IPC class: | A61K 39/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs | ||||||||
| Applicant name: | Boehringer Ingelheim Vetmedica, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request: Two independent claims for the same medical use; one claim under the provisions of EPC 1973 invoking legal fiction in G 5/83 and other claim under the provisions of Article 54(5) EPC 2000 (yes) Main request: allowable (yes) |
||||||||
| Catchwords: |
see points 34 to 49 |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111021eu1.html
Date retrieved: 17 May 2021